News Center

Home page

Peak Report

News reports

Pro 2014-020 (Framework Agreement on Jianfeng Group's Acquisition of Nestor)

Release time:

2020-08-05

Securities Code: 600668 Securities Short Name: Jianfeng Group Announcement No.: 2014-020

Bond Short Name: 13 Jianfeng 01 Bond Code: 122227

Zhejiang Jianfeng Group Co., Ltd.

Reminder Announcement on the Signing of Equity Transfer Framework Agreement by Subsidiaries

The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.

Important Content Reminder:

l Transaction Brief Content: Zhejiang Jianfeng Pharmaceutical Co., Ltd., the company's holding subsidiary, recently signed the "Framework Agreement on Equity Transfer of Zhejiang Neshikang Pharmaceutical Co., Ltd." with Creative Medicine and Xi 'an Zizhitong Investment Co., Ltd. to transfer 70% and 25% of the equity of Zhejiang Neshikang Pharmaceutical Co., Ltd.

l This transaction does not constitute a related party transaction

l This transaction does not constitute a major asset reorganization

l There are no major legal obstacles to the implementation of the transaction

l This is a framework agreement, which is the preliminary result of the preliminary negotiations, and the follow-up work has been arranged. The specific matters of equity acquisition need to be further negotiated according to the results of audit, evaluation and due diligence. The formal equity transfer agreement will also be submitted to the company's board of directors or general meeting of shareholders for approval in accordance with the "Stock Listing Rules", the company's articles of association, etc., before it can take effect. There is uncertainty as to whether the equity acquisition will be realized.

Overview of 1. Transaction

Basic Information of (I) Transaction

Zhejiang Jianfeng Pharmaceutical Co., Ltd. (hereinafter referred to as "Jianfeng Pharmaceutical"), the controlling subsidiary of the Company, plans to acquire 70% equity of Zhejiang Neisikang Pharmaceutical Co., Ltd. (hereinafter referred to as "Neisikang Pharmaceutical") held by Creative Medicine (hereinafter referred to as "CM Company") and Xi 'an Zizhitong Investment Co., Ltd. The company (hereinafter referred to as "Zizhitong Company") holds a 25% stake in Nesikang Pharmaceuticals, the total of the two is 95% equity.

(II) company approval.

This is a framework agreement. The specific matters of the equity acquisition need to be further negotiated and negotiated based on due diligence, audit or evaluation results, and will be in accordance with the provisions of the Stock Listing Rules, the company's articles of association, etc. It can be implemented after being submitted to the company's board of directors or shareholders meeting for approval. There is the possibility of changes in the implementation and implementation process of the framework agreement.

This equity transfer does not involve connected transactions, nor does it constitute a major asset reorganization as stipulated in the Measures for the Administration of Major Asset Reorganization of Listed Companies.

Basic Information of 2. Counterparty

(I) Creative Medicine

, Enterprise Name: Creative Medicine

2, Enterprise Nature: Limited Liability Company

3, Place of Registration: Cayman

, Main Office Location: 190 Elgin Street, Grand Cayman, Cayman Islands, ( KY1-9005)

, Legal Representative: Yang Zhi

, Paid-in Capital: US $13.5 million

7, Main Business: Investment and Investment Management

, Major Shareholder or Actual Controller: bioVeda China Fund II L.P.;New Enterprise Associates 13,Limited Partnership;Yifang Technology Group, Ltd.

9, 2013 main financial indicators: total assets of $41.0119 million, net assets of $13.3334 million, net profit of-$2800.

(II) Xi' an zizhitong investment co., ltd.

1, enterprise name: Xi' an zizhitong investment co., ltd.

2, enterprise nature: limited liability company (natural person investment or holding)

3, place of registration:

4 on the east side of the 10th floor of Zhongsheng Building, 69 Jinye Road, Xi 'an High-tech Zone, main office location:

5 on the east side of the 10th floor of Zhongsheng Building, 69 Jinye Road, Xi 'an High-tech Zone, legal representative: Zhang Hua

6, registered capital: 100 million yuan

7, main business: industrial investment and venture investment; asset management (excluding financial services), investment management and consulting.

8, major shareholder or actual controller: Zhang Hua

9, main financial indicators for 2013 (RMB): total assets of 257.0996 million yuan, net assets of 104.9223 million yuan, net profit of -5.3861 million yuan.

Basic Information of 3. Transaction Target

1, Target Name: 95 Equity of Zhejiang Nesikang Pharmaceutical Co., Ltd.;

2, major shareholder: CM Company holds 70% equity; Zizhitong Company holds 25% equity; zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. holds a 5% stake;

3, legal representative: Yang Zhi;

4, main business: drug bulk drug production; The main products are karat , azithromycin , fenofibrate, etc.

5, registered capital: US $36.10667 million;

6, Company Type: Limited Liability Company (Sino-foreign Joint Venture)

7, Establishment Date: December 23, 2002;

8, place of registration: 1318 Jinsha Street, Linjiang Industrial Zone, Wucheng District, Jinhua City;

9, Nesikang Pharmaceutical's 2013 financial report was audited by Jinhua Zhongjian Joint Accounting Firm, with main financial indicators:

Project (RMB 10,000)	at the end of 2013
Total Assets	43625.72
Total Liabilities	26889.44
Net Assets	16736.28
	2013
Operating Income	28776.51
Net Profit	435.01

The company will entrust an audit institution with securities and futures business qualifications to carry out necessary audit on the financial statements of Neisikang Pharmaceutical, the audit results may differ from the above financial data. Main Contents of

4. Framework Agreement

"Party A": Zhejiang Jianfeng Pharmaceutical Co., Ltd.

"Party B": creative Medicine and Xi' an zizhitong investment co., ltd.

(I) equity transfer, price payment

1.CM company jointly transferred its 70% equity of nesikang pharmaceutical and zizhitong company its 25% equity of nesikang pharmaceutical to party a.

2, A and B agree on the transfer price after considering the audit, evaluation report, market trend and other comprehensive factors that may affect the operation efficiency.

3. The transfer price will be priced in RMB and paid to Party B in installments.

(II) Assets Evaluation

Within 15 working days after the signing of the framework agreement, intermediary agencies with securities qualification such as audit and evaluation hired by Party A and approved by Party B shall conduct a comprehensive audit, evaluation and due diligence on Neisikang Pharmaceutical, and strive to complete the audit, evaluation and due diligence within no more than 30 working days. Naisikang Pharmaceuticals and Party B shall provide the greatest convenience for the audit, evaluation and due diligence work, provide relevant information in a timely manner, and undertake to provide complete and true information required for the audit, evaluation and due diligence work. Otherwise, it will bear the corresponding legal responsibility.

(III) exclusive matters

Unless approved in writing by Party A, within 60 working days after this agreement comes into effect (hereinafter referred to as exclusive period), party B and any representative under its control shall not, directly or indirectly, seek to contact, negotiate, negotiate or sign any agreement or letter of intent with any third party (whether or not such agreement or letter of intent is binding on it) with respect to any matter agreed upon in this Agreement. During the exclusive period, Party B shall ensure the achievement of the transfer conditions, and the Buyer shall draft the equity transfer agreement and other transaction documents for negotiation. The term of this agreement and the exclusive period may be extended with the consent of the parties.

5. the impact and risk tips of this transaction

This equity acquisition is the specific implementation of the company's strategic plan and 2014 business plan. If the equity transfer can be successfully completed, it will expand the scope and scale of the company's pharmaceutical business.

In view of the fact that this framework agreement only determines the basic framework of the transaction, it is still necessary to further reach an equity transfer agreement on the basis of audit, evaluation and due diligence, and submit it to the company's board of directors or shareholders' meeting for consideration. There is uncertainty about whether the transaction can be realized. The company will be based on the progress of the acquisition of the progress of the timely disclosure of the follow-up progress, so that the majority of investors pay attention to investment risks.

hereby announce

Zhejiang Jianfeng Group Co., Ltd.

Board of Directors

July 28, 2014

More information

The company's vocational skill level self-identification training began.

After preparing the handout materials and question bank for the previous stage of vocational skill grade identification training, daye peak cement company conducted the vocational skill grade identification training for the machine repair team of the manufacturing department on August 10. On August 12 and 18, the pharmaceutical company also organized two phases of vocational skill level identification training for pharmaceutical preparation workers. According to the national skill level standard, the group company is divided into four grades: grade 5/junior worker, grade 4/intermediate worker, grade 3/senior worker and grade 2/technician. According to the analysis of employee registration, since there is only one type of job for pharmaceutical preparation workers, and cement production workers include cement central controller, cement quality inspector, cement clinker calciner, cement manufacturer, cement production inspection worker and other types of jobs, the number of applicants is less than that of cement production workers. Most of the employees who signed up were identified as participating in the four levels of vocational skills. According to preliminary statistics, there are now 155 employees who have signed up for their professional skill level, including 47 pharmaceutical preparation workers and 108 cement production workers. The human resources department of the group company is stepping up efforts to organize personnel to examine the qualifications of the employees whose registration grades are identified, and then enter the Zhejiang professional ability integration platform for formal registration after passing the examination. According to the national vocational skill standards and other content, each unit carries out targeted training for employees who participate in the independent identification of vocational skill levels. The training is conducted through on-site teaching, online teaching, and learning platform question bank exercises. After the training, the group company will organize the employees who participate in the grade identification to carry out examination and assessment, and those who pass the examination will complete the grade identification and issue the skill grade certificate. It is understood that in order to ensure the quality of vocational skill level identification, after the company was approved to independently identify the vocational skill level, the human resources department of the group organized all units to compile the question bank for various types of work in combination with the actual situation of the enterprise and with reference to the national vocational skill standards and training syllabus and other materials. after classification, unification and standardization, verification and proofreading, the preparation of the question bank has been basically completed. After being submitted to the superior unit for examination and approval, the company will import the question bank on the enterprise university platform to facilitate employees to prepare for the examination. The question bank for the independent identification of vocational skills level will also be extracted from the question banks of various industries, including professional ethics, basic knowledge, safety and environmental protection knowledge, laws and regulations knowledge, professional work practice and other national vocational skills standards. Basic requirements. The examination and assessment for independent determination of vocational skill level is tentatively scheduled for mid-September.

2021

08-23

Hu Guoyun, vice mayor of Pu'er, visited the peak

On July 16, a delegation led by Hu Guoyun, vice mayor of Pu'er City, Yunnan Province, and heads of Pu'er SASAC, Industrial Park Management Committee, Investment Promotion Bureau and other departments visited the headquarters of the group company. In the exchange with Jiang Xiaomeng, Yu Jianhong and other group leaders, Hu Guoyun expressed his gratitude to Jianfeng Group on behalf of the Pu'er Municipal Party Committee and Municipal Government. He said that the investment and entrepreneurship from Jianfeng to Pu'er not only promoted the development of Pu'er's regional industrial economy, but also made outstanding contributions to the local poverty alleviation. The two sides also exchanged and discussed issues such as strengthening in-depth cooperation between the two sides.

2021

07-21

Municipal SASAC Party Committee Visited Jianfeng Old Party Member

On June 28, Huang Zunhui, a second-level researcher of the State-owned Assets Supervision and Administration Commission of Jinhua City, visited Jianfeng Group and made a special trip to visit two retired party members, Chen Bingxiang and Yin Rongfu. Among the two Jianfeng veteran party members, Chen Bingxiang has been engaged in party affairs for nearly 30 years, and Yin Rongfu has won the honor of outstanding party members in Zhejiang Province and is a representative of Jianfeng party workers and party members. On behalf of the party committee of the Municipal State-owned assets Supervision and Administration Commission, Huang Zunhui expressed condolences to the two veteran party members, thanked the older generation of party members for their contributions, and exchanged views with Jiang Xiaomeng, secretary of the party committee and chairman of the group, and Qin Xuping, member of the party committee and chairman of the trade union, and fully affirmed the development of peak in recent years and the improvement of the level of party building work.

2021

07-12

"I'll teach you a lesson." Concluded successfully.

On the afternoon of June 24, as one of the highlights of the company's 2021 safety production month series of activities, the second phase of the "I'll give you a lesson" safety training was held at the group headquarters. the management personnel, production backbones and personnel from all departments and offices of the group gathered at the scene. foreign enterprises took safety "big lessons" through video, which was more effective than the teaching. At this point, the "I'll give you a lesson" safety training has come to a successful conclusion.

2021

07-12

Glory in the Party's 50-year-old Party Member Xi Ling Commemorative Medal

On June 23, the party committee of the group company sent a special person to visit and awarded the commemorative medals of "50 years of Glory in the Party" to six veteran party members. 2021 is the 100 anniversary of the founding of the Communist Party of China. For the first time, the Party Central Committee issued the "50 Years of Glory in the Party" commemorative medal to surviving party members who have reached the 50th anniversary of the party and have always performed well. The Organization Department of the Central Committee also specially issued the "Administrative Measures for the Issuance of Commemorative Medals of" Glory in the Party for 50 Years "", which stipulates the issuance procedures, issuance methods, production, and management of commemorative medals. In the future, the "50 Years of Glory in the Party" commemorative medal will be issued as a regular task and will be issued once every year around July 1.

2021

07-12

Return to the scene of party history and reproduce the moment of party history. The party committee of the group organizes special party lessons to study.

What is the exact time of the first Congress of the Communist Party of China? Which "big" representatives boarded the red boat in South Lake? What is the connection between the 1972 Sino-US Joint Communique and Hangzhou? On the morning of June 24th, the Party Committee of the Group Company invited members of the Party History Learning and Education Group of Zhejiang Provincial Party Committee and the vice president of Zhejiang Branch of China News Service to give a special party class of "returning to the scene of party history and reappearing the moment of party history" for the party members and cadres of the Company.

2021

07-01

< 1...9 10 11...61 > 跳转到页